@m5v88:

𝙼𝚞𝚗𝚒𝚛𝚊🇸🇦
𝙼𝚞𝚗𝚒𝚛𝚊🇸🇦
Open In TikTok:
Region: SA
Monday 03 August 2026 21:05:09 GMT
4147
237
2
31

Music

Download

Comments

t8.1l
💛 :
يارب
2026-08-04 04:03:32
0
aay20705
ثقتي باربي تكفيني :
يارب
2026-08-03 21:11:46
0
To see more videos from user @m5v88, please go to the Tikwm homepage.

Other Videos

🧬 For the first time in history, scientists are testing whether aged human cells can become younger again. Every cell in your body carries the same DNA throughout your life. What changes as you age is the epigenome the layer of chemical instructions that tells your genes when to turn on or off. Over time, these instructions drift, and cells gradually lose many of their youthful functions. This breakthrough builds on Nobel Prize-winning research by Shinya Yamanaka, who discovered that four special factors can completely reset mature cells into stem cells. While revolutionary, that approach can erase a cell’s identity, making it unsuitable for many therapeutic applications. A new investigational therapy called ER-100 takes a different path. Instead of using all four Yamanaka factors, it uses only OCT4, SOX2, and KLF4, leaving out the fourth, higher-risk factor. The goal is to partially reset the cell’s biological clock while preserving its original function. In animal studies, this approach restored aging retinal cells and improved vision, building on earlier research from David Sinclair and colleagues published in Nature (2020). On January 28, 2026, the U.S. FDA cleared ER-100 to begin its first human clinical trial. The therapy will be injected into the eye to evaluate its safety and potential effectiveness for treating optic neuropathies. This is the first partial cellular reprogramming therapy to enter human testing. While the results in animals have been promising, it is important to remember that this is an early Phase 1 clinical trial, designed primarily to assess safety. Whether it will work in humans remains unknown. If successful, this research could reshape how we think about aging not simply slowing it, but potentially restoring the function of aging cells, one cell at a time. 🔬 Science is taking another bold step forward but the real answers will come from carefully conducted human studies. 📚 Sources: Life Biosciences (FDA IND clearance, January 28, 2026); Lu et al., Nature (2020). ⚠️ Educational purposes only. This is not medical advice. ER-100 is an investigational therapy in early-stage clinical trials, and its safety and effectiveness have not yet been established. #Science #Longevity #Aging #Epigenetics #CellReprogramming
🧬 For the first time in history, scientists are testing whether aged human cells can become younger again. Every cell in your body carries the same DNA throughout your life. What changes as you age is the epigenome the layer of chemical instructions that tells your genes when to turn on or off. Over time, these instructions drift, and cells gradually lose many of their youthful functions. This breakthrough builds on Nobel Prize-winning research by Shinya Yamanaka, who discovered that four special factors can completely reset mature cells into stem cells. While revolutionary, that approach can erase a cell’s identity, making it unsuitable for many therapeutic applications. A new investigational therapy called ER-100 takes a different path. Instead of using all four Yamanaka factors, it uses only OCT4, SOX2, and KLF4, leaving out the fourth, higher-risk factor. The goal is to partially reset the cell’s biological clock while preserving its original function. In animal studies, this approach restored aging retinal cells and improved vision, building on earlier research from David Sinclair and colleagues published in Nature (2020). On January 28, 2026, the U.S. FDA cleared ER-100 to begin its first human clinical trial. The therapy will be injected into the eye to evaluate its safety and potential effectiveness for treating optic neuropathies. This is the first partial cellular reprogramming therapy to enter human testing. While the results in animals have been promising, it is important to remember that this is an early Phase 1 clinical trial, designed primarily to assess safety. Whether it will work in humans remains unknown. If successful, this research could reshape how we think about aging not simply slowing it, but potentially restoring the function of aging cells, one cell at a time. 🔬 Science is taking another bold step forward but the real answers will come from carefully conducted human studies. 📚 Sources: Life Biosciences (FDA IND clearance, January 28, 2026); Lu et al., Nature (2020). ⚠️ Educational purposes only. This is not medical advice. ER-100 is an investigational therapy in early-stage clinical trials, and its safety and effectiveness have not yet been established. #Science #Longevity #Aging #Epigenetics #CellReprogramming

"Tự tin mặc bikini bắt đầu từ việc dọn lông gọn gàng 👙 Không biết có chị em nào cũng thường xuyên đi biển và thích mặc bikini giống mình không? Nhưng đôi khi mình thật sự lo phần lông ở viền bikini vô tình bị lộ ra ngoài, chụp ảnh cũng không dám tạo dáng thoải mái. Vì vậy mình đã dùng kem tẩy lông Dr.Eyemo để tự xử lý tại nhà, vừa tiện vừa đỡ gặp tình huống ngại ngùng khi mặc bikini. Cách dùng khá đơn giản, chỉ cần thoa đều kem lên vùng lông cần làm sạch, đợi đúng thời gian hướng dẫn rồi nhẹ nhàng lau và rửa sạch lại với nước. Sau khi làm sạch, vùng da nhìn gọn gàng và mịn hơn, cũng đỡ cảm giác lông đen, cứng và lởm chởm như sau khi dùng dao cạo. Mình thấy rất phù hợp với những bạn mới bắt đầu tự tẩy lông tại nhà, không cần chuẩn bị quá nhiều dụng cụ, dùng cũng khá tiện. ⚠️ Chỉ nên dùng ở vùng da bên ngoài như đường viền bikini, chân, tay hoặc nách. Không thoa vào vùng kín bên trong, niêm mạc, vùng da trầy xước hoặc đang kích ứng. Nhớ thử trước trên một vùng da nhỏ và làm đúng hướng dẫn trên bao bì nhé! Dọn sạch gọn gàng xong là có thêm tự tin để mặc bikini và chụp thật nhiều ảnh đẹp rồi 📸✨ #DrEyemo #KemTayLongDrEyemo #KemTayLong #TayLongVungBikini #taylongtainha

About